Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4396264 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRB | |
| SCHEMBL2653 | 0.97 | — | — | |
| SCHEMBL827285 | 0.86 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL126792 | 0.86 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL813378 | 0.86 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL9176896 | 0.85 | ALDH1A1 (0.35) | ALDH1A1TSHRTHRB | |
| SCHEMBL27905163 | 0.84 | MEN1 (0.42) | ALDH1A1TSHRTHRB | |
| SCHEMBL5401232 | 0.84 | CYP3A4 (0.33) | TSHRTHRB | |
| SCHEMBL4397692 | 0.84 | — | — | |
| SCHEMBL4396233 | 0.84 | CYP3A4 (0.33) | TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9487494-B2 | Cyclic hydrocarbon compounds for the treatment of diseases | LEO PHARMA A/S (DK) | 2016-11-08 | — | — | US | claimed |
| US-20100317582-A1 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2010-12-16 | — | — | US | claimed |
| EP-2234961-A2 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2010-10-06 | — | — | EP | claimed |
| WO-2009065406-A2 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2009-05-28 | — | — | WO | claimed |
| US-7176234-B2 | Anticancer agents; side effect reduction | CYTOVIA, INC. (US) | 2007-02-13 | — | — | US | claimed |
| US-20040082066-A1 | Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis | CYTOVIA, INC. | 2004-04-29 | — | — | US | claimed |
| US-5631354-A | ERYTHROMYCIN DERIVATIVES WITH IMPROVED ANTIBACTERIAL ACTIVITY | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1997-05-20 | — | — | US | claimed |
| US-5523399-A | MACROLIDE ANTIBIOTICS HAVING A STRONG ANTIBACTERIAL ACTIVITY | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1996-06-04 | — | — | US | claimed |
| US-20240182631-A1 | RANDOM COPOLYMER AND METHOD OF PRODUCING SAME | ZEON CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4317241-A1 | RANDOM COPOLYMER AND METHOD FOR MANUFACTURING SAME | Zeon Corporation (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-116964124-A | Random copolymer and method for producing same | 日本瑞翁株式会社 | 2023-10-27 | — | — | CN | disclosed |
| WO-2022210407-A1 | RANDOM COPOLYMER AND METHOD FOR MANUFACTURING SAME | 日本ゼオン株式会社 | 2022-10-06 | — | — | WO | disclosed |
| CN-107496181-B | Solubilization system containing resveratrol | 上海家化联合股份有限公司 | 2021-03-09 | — | — | CN | disclosed |
| WO-2017037293-A1 | METHOD FOR INDUCING DIFFERENTIATION OF STEM CELLS | STICHTING KATHOLIEKE UNIVERSITEIT (NL) | 2017-03-09 | — | — | WO | disclosed |
| US-5523399-A | MACROLIDE ANTIBIOTICS HAVING A STRONG ANTIBACTERIAL ACTIVITY | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1996-06-04 | — | — | US | disclosed |
| EP-0501167-B1 | Liquid dye preparations | BASF AG (DE) | 1995-07-05 | — | — | EP | disclosed |
| EP-0619319-A1 | 5-0-DESOSAMINYLERYTHRONOLIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1994-10-12 | — | — | EP | disclosed |
| EP-0619320-A1 | 5-O-DESOSAMINYLERYTHRONOLIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1994-10-12 | — | — | EP | disclosed |
| US-5205838-A | LIQUID DYE PREPARATIONS: BIS PHENYL-AZO-RESORCINOL IN SOLVENT FOR COLORED RIBBON OR BALL PEN INK | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-27 | — | — | US | disclosed |
| EP-0501167-A1 | Liquid dye preparations | BASF Aktiengesellschaft (DE) | 1992-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317582-A1 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | ARNT, AHR, CYP27A1 | ALDH1A1 1743/4885TSHR 1795/4885THRB 1280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.